Biogen stockholders elect ten directors and ratify PricewaterhouseCoopers
Stockholders also approved executive compensation in an advisory vote at the June 9, 2026 annual meeting.
GetSignal Biogen BIIB
Biogen stockholders elected ten nominees to the board of directors at the company's 2026 annual meeting, held June 9, 2026. The nominees were elected to one-year terms extending until the 2027 annual meeting, or until their successors are duly elected and qualified.
Stockholders ratified PricewaterhouseCoopers LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026, with 124,551,887 votes for and 6,627,086 against.
Key facts
- Meeting date
- June 9, 2026
- Directors elected
- 10 nominees
- Director term
- Until the 2027 annual meeting
- Auditor ratified
- PricewaterhouseCoopers LLP, fiscal year ending December 31, 2026
Source: Form 8-K filed June 10, 2026.
Written by GetSignal with AI from the company's SEC filing.
Not investment advice.
